Revvity - 52 Year Stock Price History | RVTY
- The all-time high Revvity stock closing price was 199.15 on December 31, 2021.
- The Revvity 52-week high stock price is 128.29, which is 37.9% above the current share price.
- The Revvity 52-week low stock price is 81.36, which is 12.6% below the current share price.
- The average Revvity stock price for the last 52 weeks is 100.49.
| Revvity Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 98.6605 | 111.6860 | 126.5580 | 82.4386 | 93.0600 | -16.39% |
| 2024 | 111.5807 | 109.8360 | 127.3170 | 98.9797 | 111.2970 | 2.37% |
| 2023 | 116.3061 | 140.0600 | 143.3510 | 81.6384 | 108.7220 | -21.87% |
| 2022 | 149.3384 | 190.3730 | 190.3730 | 116.0510 | 139.1470 | -30.13% |
| 2021 | 157.7078 | 143.8610 | 199.1480 | 119.0410 | 199.1480 | 40.37% |
| 2020 | 105.9401 | 97.4667 | 146.2330 | 65.8151 | 141.8730 | 48.20% |
| 2019 | 88.5973 | 75.5968 | 99.4642 | 71.5378 | 95.7315 | 24.01% |
| 2018 | 79.1562 | 72.3841 | 95.5224 | 70.6336 | 77.1987 | 7.80% |
| 2017 | 62.4888 | 51.6607 | 72.3156 | 50.3429 | 71.6104 | 40.85% |
| 2016 | 50.4351 | 50.8380 | 55.4199 | 40.2495 | 50.8417 | -2.12% |
| 2015 | 48.1753 | 42.5050 | 52.7094 | 41.1264 | 51.9434 | 23.21% |
| 2014 | 42.6446 | 39.2135 | 46.3646 | 38.3316 | 42.1579 | 6.75% |
| 2013 | 33.7241 | 30.4889 | 39.6062 | 28.9535 | 39.4913 | 30.95% |
| 2012 | 25.9166 | 19.3605 | 30.6789 | 19.1443 | 30.1564 | 60.44% |
| 2011 | 22.2613 | 24.0576 | 26.5785 | 16.4376 | 18.7966 | -21.63% |
| 2010 | 20.8715 | 18.9252 | 24.2805 | 17.4924 | 23.9833 | 27.03% |
| 2009 | 15.2519 | 12.7664 | 19.1794 | 9.9597 | 18.8793 | 50.65% |
| 2008 | 21.8040 | 22.7420 | 26.6660 | 11.8385 | 12.5322 | -45.93% |
| 2007 | 23.0557 | 19.2878 | 26.5341 | 18.8561 | 23.1785 | 18.33% |
| 2006 | 18.6163 | 20.8630 | 21.0046 | 15.7076 | 19.5874 | -4.40% |
| 2005 | 18.1466 | 18.9518 | 20.7500 | 15.5585 | 20.4891 | 6.19% |
| 2004 | 16.5769 | 14.8288 | 19.6381 | 13.4509 | 19.2950 | 33.78% |
| 2003 | 10.9148 | 7.2811 | 15.7751 | 6.1575 | 14.4232 | 112.02% |
| 2002 | 10.4093 | 27.9905 | 28.9744 | 3.6035 | 6.8029 | -75.72% |
| 2001 | 25.7474 | 38.4500 | 39.6640 | 16.9719 | 28.0145 | -32.69% |
| 2000 | 29.6615 | 16.2769 | 47.3688 | 15.3440 | 41.6212 | 154.17% |
| 1999 | 13.0210 | 11.1184 | 17.2098 | 9.9863 | 16.3751 | 52.57% |
| 1998 | 10.2827 | 7.8764 | 12.8603 | 7.4284 | 10.7325 | 36.67% |
| 1997 | 7.6693 | 7.2982 | 8.9190 | 6.7470 | 7.8529 | 6.26% |
| 1996 | 7.4535 | 8.5219 | 8.8935 | 6.0111 | 7.3900 | -14.62% |
| 1995 | 6.1081 | 4.9962 | 8.6558 | 4.5735 | 8.6558 | 79.38% |
| 1994 | 5.3884 | 5.8598 | 6.3210 | 4.7406 | 4.8254 | -20.45% |
| 1993 | 6.6884 | 6.3942 | 7.9344 | 5.2844 | 6.0662 | -3.92% |
| 1992 | 7.2867 | 7.6466 | 8.4072 | 5.8312 | 6.3138 | -19.71% |
| 1991 | 6.3790 | 4.8909 | 7.8639 | 4.8522 | 7.8639 | 64.03% |
| 1990 | 5.5575 | 5.2226 | 6.2533 | 4.3302 | 4.7942 | -6.85% |
| 1989 | 4.8875 | 4.2416 | 5.5064 | 4.2416 | 5.1469 | 20.82% |
| 1988 | 4.7824 | 4.9121 | 5.6118 | 4.0378 | 4.2601 | -11.97% |
| 1987 | 5.0929 | 4.0456 | 6.4897 | 4.0456 | 4.8394 | 19.62% |
| 1986 | 4.8422 | 5.3962 | 6.0350 | 3.9922 | 4.0456 | -25.27% |
| 1985 | 5.2714 | 4.3851 | 5.9751 | 4.3851 | 5.4139 | 22.97% |
| 1984 | 4.2598 | 4.4316 | 4.8955 | 3.6644 | 4.4026 | -1.42% |
| 1983 | 4.4181 | 3.6808 | 5.1917 | 3.6638 | 4.4660 | 15.96% |
| 1982 | 2.7246 | 2.6243 | 4.1069 | 1.9767 | 3.8512 | 43.03% |
| 1981 | 2.6242 | 2.9481 | 2.9651 | 2.2324 | 2.6925 | -9.45% |
| 1980 | 2.2553 | 1.6061 | 3.2889 | 1.5678 | 2.9736 | 78.51% |
| 1979 | 1.1827 | 0.9714 | 1.6658 | 0.8861 | 1.6658 | 68.54% |
| 1978 | 0.8560 | 0.5836 | 1.1162 | 0.5624 | 0.9884 | 63.37% |
| 1977 | 0.6275 | 0.6135 | 0.7285 | 0.5453 | 0.6050 | 4.42% |
| 1976 | 0.5501 | 0.4985 | 0.6646 | 0.4644 | 0.5794 | 20.36% |
| 1975 | 0.4971 | 0.4346 | 0.6646 | 0.3493 | 0.4814 | 13.00% |
| 1974 | 0.4009 | 0.6135 | 0.6774 | 0.2428 | 0.4260 | -29.59% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.324B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $155.708B | 28.59 |
| HCA Healthcare (HCA) | United States | $108.871B | 18.02 |
| CVS Health (CVS) | United States | $99.536B | 11.45 |
| Elevance Health (ELV) | United States | $73.541B | 10.79 |
| Cencora (COR) | United States | $70.765B | 22.83 |
| Natera (NTRA) | United States | $28.437B | 0.00 |
| DiDi Global (DIDIY) | China | $22.826B | 18.65 |
| Labcorp Holdings (LH) | United States | $21.668B | 16.52 |
| Medpace Holdings (MEDP) | United States | $16.500B | 40.96 |
| BioMerieux (BMXMF) | France | $14.511B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.409B | 0.00 |
| Solventum (SOLV) | United States | $13.215B | 12.83 |
| ICON (ICLR) | Ireland | $12.638B | 12.54 |
| Viatris (VTRS) | United States | $12.278B | 4.58 |
| CochLear (CHEOY) | Australia | $11.483B | 0.00 |
| HealthEquity (HQY) | United States | $8.630B | 34.54 |
| Charles River Laboratories (CRL) | United States | $8.009B | 15.43 |
| Avantor (AVTR) | United States | $7.418B | 11.33 |
| Sonic Healthcare (SKHHY) | Australia | $6.697B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.690B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.656B | 33.72 |
| Bausch + Lomb (BLCO) | Canada | $5.313B | 34.88 |
| Sotera Health (SHC) | United States | $4.335B | 20.90 |
| GeneDx Holdings (WGS) | United States | $3.745B | 65.76 |
| Amplifon S.p.A (AMFPF) | Italy | $3.560B | 20.77 |
| Alignment Healthcare (ALHC) | United States | $3.209B | 0.00 |
| Concentras Parent (CON) | United States | $2.466B | 15.39 |
| PACS (PACS) | United States | $2.393B | 0.00 |
| Premier (PINC) | United States | $2.327B | 22.55 |
| Progyny (PGNY) | United States | $2.312B | 45.46 |
| Organon (OGN) | United States | $1.989B | 2.10 |
| Pediatrix Medical (MD) | United States | $1.977B | 11.81 |
| Surgery Partners (SGRY) | United States | $1.948B | 25.10 |
| Establishment Labs Holdings (ESTA) | United States | $1.913B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.198B | 0.00 |
| Ardent Health (ARDT) | United States | $1.186B | 3.87 |
| Omada Health (OMDA) | $1.127B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $0.967B | 15.83 |
| Embecta (EMBC) | United States | $0.837B | 4.90 |
| CareDx (CDNA) | United States | $0.798B | 13.03 |
| InnovAge Holding (INNV) | United States | $0.674B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.611B | 8.41 |
| Sonida Senior Living (SNDA) | United States | $0.601B | 0.00 |
| Nutex Health (NUTX) | United States | $0.577B | 8.74 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.512B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Pomdoctor - (POM) | China | $0.438B | 0.00 |
| CryoPort (CYRX) | United States | $0.426B | 0.00 |
| Enhabit (EHAB) | United States | $0.404B | 18.16 |
| Auna S.A (AUNA) | Luxembourg | $0.370B | 5.56 |
| Strata Critical Medical (SRTA) | United States | $0.364B | 0.00 |
| Oncology Institute (TOI) | United States | $0.353B | 0.00 |
| So-Young (SY) | China | $0.338B | 0.00 |
| SBC Medicals (SBC) | United States | $0.315B | 5.73 |
| Shoulder Innovations (SI) | United States | $0.298B | 0.00 |
| KindlyMD (NAKA) | United States | $0.243B | 0.00 |
| LifeMD (LFMD) | United States | $0.224B | 0.00 |
| Agilon Health (AGL) | United States | $0.223B | 0.00 |
| Beauty Health (SKIN) | United States | $0.162B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.159B | 33.37 |
| Sera Prognostics (SERA) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| DocGo (DCGO) | United States | $0.094B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.024B | 7.28 |
| Basel Medical Group (BMGL) | Singapore | $0.021B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.019B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |